SLS
SELLAS Life Sciences Group Inc
-63.99%
$3.61 - $1.30
Feb 7th 2023 - Mar 21st 2023
Mar, 20, 2023
These patients experienced about 35% longer surviv... See more
Mar, 20, 2023
* Best Available Therapy offers 6-8 months of Over... See more
PPBT
Purple Biotech Ltd - ADR
10.58%
$1.89 - $2.09
Feb 7th 2023 - Mar 21st 2023
Mar, 15, 2023
$PPBT happy that Dr. Curran is on our MD Anderson ... See more
Jan, 3, 2023
$PPBT cure for cancer 5% up….
SRNE
Sorrento Therapeutics Inc
-69.12%
$1.02 - $0.32
Feb 2nd 2023 - Mar 10th 2023
Feb, 22, 2023
We will continue our important work of developing ... See more
Jan, 22, 2023
With the ease of rapid, large scale Good Manufactu... See more
Mar, 20, 2023
These patients experienced about 35% longer survival than has been reported for other second-line therapies.
Mar, 20, 2023
* Best Available Therapy offers 6-8 months of Overall Survival * All pooled Regal patients, BAT and Gps combined, is 16 months.
Mar, 17, 2023
* Best Available Therapy offers 6-8 months of Overall Survival * All pooled Regal patients, BAT and Gps combined, is 16 months.
Mar, 17, 2023
* Best Available Therapy offers 6-8 months of Overall Survival * All pooled Regal patients, BAT and Gps combined, is 16 months.
Mar, 13, 2023
Good cancer stock from what I hear in 2028.
Feb, 6, 2023
$MRK Ovarian cancer data final P2 results are better than any other drugs by a mile.
Feb, 3, 2023
They address a broad range of cancer indications.
Feb, 3, 2023
$SLS Gps arm 22 months of median Overall Survival Best Available Therapy 8.
Feb, 1, 2023
$SLS In addition to GPs FDA approval for AML secondary Remission patients - Gps + Keytruda/Checkpoint Inhibition is also best in class for Ovarian cancer patients.
Jan, 24, 2023
The nation’s best means the O'Neal Comprehensive Center in Alabama have access to the latest therapies, cutting-edge clinical trials and the expertise needed to treat their cancer.
Mar, 15, 2023
$PPBT happy that Dr. Curran is on our MD Anderson team… glioblastoma 😉
Jan, 3, 2023
$PPBT cure for cancer 5% up….
Dec, 30, 2022
but I find it good therapy and it is too early to start drinking 😂
Dec, 20, 2022
This thing is showing huge promise with (blood) cancer.
Dec, 14, 2022
The data (if that’s even real at this point) is incredible - find me a preliminary phase 2 cancer drug that caused complete remission in multiple patients at THE LOWEST DOSE!!
Dec, 13, 2022
MRNA showing promise in their cancer vaccine.
Dec, 6, 2022
It got fast fda tracked with their trial ongoing with Roche as the partner for pancreatic cancer 🤷🏻♂️👀
Dec, 1, 2022
It’s pharmakinetics are simply the most promising on the market for hard-to-treat cancers.
Nov, 30, 2022
$PPBT Lot of preclinical research with 157 in many countries, targeting different cancers and showing promising results.
Sep, 29, 2022
Also One of the best cancer center.
Feb, 22, 2023
We will continue our important work of developing new and innovative therapies for patients struggling with cancer, intractable pain, infectious disease, and more.
Jan, 22, 2023
With the ease of rapid, large scale Good Manufacturing Practice-grade mRNA production, mRNA is ideally poised not only for off-the shelf cancer vaccines
Jan, 18, 2023
$SRNE your money is well spent , your helping research cancer & everyone here has lost a loved one https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/immunotherapy.html
Dec, 10, 2022
It‘s extremely distracting because this woman might have the most perfect breast I have ever seen.
Nov, 9, 2022
$SRNE $THER Ther good buy with $1 target with cancer assay news https://www.prnewswire.com/news-releases/theralink-technologies-appoints-dr-mattia-cremona-as-its-director-of-its-biopharma-laboratory-301669138.html